Safety Recall: Saishunkan Seiyaku Medicated Beauty Serum and Medicated Cream – Japan CAA

Published by Reclia Safety Desk | June 29, 2026

Recall Information Record

Case Number: 00000035449
Product: Medicated Beauty Serum and Medicated Cream
Brand: Saishunkan Seiyaku
Hazards: Safety Risk
Source: Japan Consumer Affairs Agency (CAA)

WHAT HAPPENED

Saishunkan Seiyaku has issued a recall for its Domohorn Wrinkle Medicated Serum b and Medicated Cream c. The recall was triggered by a procedural failure: the products were shipped before the mandatory release judgment procedures were completed, despite having passed all required tests and inspections. This oversight raises concerns about compliance with Good Manufacturing Practice (GMP) standards in Japan.

While no safety issues have been identified in the products themselves, the lack of proper documentation and release authorization means the company cannot fully guarantee the traceability and quality assurance of the affected batches. The recall is a precautionary measure to uphold regulatory integrity and consumer trust. The Consumer Affairs Agency (CAA) has listed this recall under management number 00000035449, with reference information provided by the Pharmaceuticals and Medical Devices Agency (PMDA).

Consumers who have purchased these products should take the following steps:

• Check the product name and packaging to confirm if you have the affected items: Domohorn Wrinkle Medicated Serum b or Medicated Cream c.
• Stop using the product immediately and contact Saishunkan Seiyaku’s customer service for return and refund instructions.
• Follow the company’s guidance for returning the product, which may include providing purchase details and shipping the items back at no cost.

AFFECTED BATCHES & TARGET SPECIFICS

– **Target Model / Type:** N/A
– **JAN Barcode:** N/A
– **Affected Serial / Lot Numbers:** N/A
– **Total Units Affected:** N/A

ADDITIONAL REGULATORY NOTES

The recall was initiated because products were shipped without completing the required release judgment procedures, although they passed testing and inspection. The recall start date is March 3, 2026. Reference information is provided by PMDA.

❓ Frequently Asked Questions